Safety and Tolerability of Dalfampridine in Subjects With Cerebral Palsy
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
A double-blind, placebo-controlled, crossover study in subjects with cerebral palsy (CP) to
evaluate the safety and tolerability and the effect of dalfampridine extended release (ER)
tablets on sensorimotor function